GlassScriptPhysician profile
Andre P Bouhasin
NPI 1508808635
$70,553.49
in general payments reported to CMS, 2019-2025
48 companies · $7,727 in 2025
The $7,727 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,756 · 2020: $2,785 · 2021: $9,019 · 2022: $37K · 2023: $4,451 · 2024: $3,805 · 2025: $7,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,261 · Consulting Fee: $5,768 · Travel and Lodging: $1,729 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,194 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,260.52 |
| Consulting Fee | $5,768.00 |
| Travel and Lodging | $1,728.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,194.00 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $34,640.34 | 2020-2024 | (Br7) Peripheral Specialty Balloon, (Br6) Re Entry, (Br5) Peripheral Ivus |
| Ge Healthcare | $13,268.13 | 2021-2025 | |
| Boston Scientific Corporation | $6,187.73 | 2019-2025 | Watchman Access System, Watchman Flx, Bodyguardian |
| Janssen Pharmaceuticals, INC | $2,236.93 | 2019-2024 | Xarelto |
| Amgen INC. | $1,595.37 | 2019-2025 | Repatha, Repatha |
| Biotronik INC. | $1,589.62 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| Novartis Pharmaceuticals Corporation | $1,385.17 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,272.93 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $1,099.23 | 2019-2025 | Farxiga, Brilinta |
| Actelion Pharmaceuticals US, INC. | $1,090.67 | 2019-2024 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $735.66 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $659.59 | 2019-2025 | Lifevest |
| United Therapeutics Corporation | $554.42 | 2019-2023 | Orenitram |
| Merck Sharp & Dohme LLC | $510.14 | 2022-2025 | Verquvo, Winrevair, Lagevrio |
| Bayer Healthcare Pharmaceuticals INC. | $457.00 | 2019-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $328.75 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $310.76 | 2020-2023 | Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Peripheral |
| Amarin Pharma, INC. | $267.79 | 2019-2022 | |
| Esperion Therapeutics, INC. | $260.22 | 2020-2024 | Nexletol |
| Pfizer INC. | $227.22 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $204.54 | 2019-2023 | |
| Novo Nordisk INC | $155.48 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Stryker Corporation | $151.50 | 2025 | Artix Mt |
| Veryan Medical Incorporated | $134.87 | 2021 | |
| Lundbeck LLC | $128.14 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $123.38 | 2019-2022 | |
| Penumbra, INC. | $123.25 | 2019 | |
| Scpharmaceuticals INC. | $85.20 | 2023-2025 | |
| Cardiovascular Systems INC. | $72.22 | 2019-2022 | |
| Acist Medical Systems, INC. | $70.15 | 2022-2025 | |
| Gilead Sciences, INC. | $67.56 | 2019 | |
| Alnylam Pharmaceuticals INC. | $65.49 | 2020-2021 | |
| Vifor Pharma, INC. | $64.33 | 2019 | |
| Cvrx, INC. | $55.35 | 2022-2025 | Barostim Neo System |
| Arbor Pharmaceuticals, INC. | $55.11 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $49.21 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $41.94 | 2022-2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $36.65 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $31.36 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $24.16 | 2022 | |
| Abiomed | $21.40 | 2024 | Impella |
| Lilly USA, LLC | $21.38 | 2025 | Zepbound |
| Edwards Lifesciences Corporation | $20.90 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $17.84 | 2024 | |
| Irhythm Technologies, INC. | $14.79 | 2019 | |
| Tactile Systems Technology INC | $13.30 | 2019 | |
| Sunovion Pharmaceuticals INC. | $13.27 | 2019 | |
| Janssen Scientific Affairs, LLC | $13.05 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Bouhasin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.